Literature DB >> 26278184

The Structure and Interactions of Periplasmic Domains of Crucial MmpL Membrane Proteins from Mycobacterium tuberculosis.

Nicholas Chim1, Rodrigo Torres1, Yuqi Liu1, Joe Capri2, Gaëlle Batot1, Julian P Whitelegge2, Celia W Goulding3.   

Abstract

Mycobacterium tuberculosis mycobacterial membrane protein large (MmpL) proteins are important in substrate transport across the inner membrane. Here, we show that MmpL proteins are classified into two phylogenetic clusters, where MmpL cluster II contains three soluble domains (D1, D2, and D3) and has two full-length members, MmpL3 and MmpL11. Significantly, MmpL3 is currently the most druggable M. tuberculosis target. We have solved the 2.4-Å MmpL11-D2 crystal structure, revealing structural homology to periplasmic porter subdomains of RND (multidrug) transporters. The resulting predicted cluster II MmpL membrane topology has D1 and D2 residing, and possibly interacting, within the periplasm. Crosslinking and biolayer interferometry experiments confirm that cluster II D1 and D2 bind with weak affinities, and guided D1-D2 heterodimeric model assemblies. The predicted full-length MmpL3 and MmpL11 structural models reveal key substrate binding and transport residues, and may serve as templates to set the stage for in silico anti-tuberculosis drug development.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MmpL; Mycobacterium tuberculosis; RND transporters; X-ray crystallography; biolayer interferometry; crosslinking; porter domain; tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26278184      PMCID: PMC4546533          DOI: 10.1016/j.chembiol.2015.07.013

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  51 in total

1.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  Structural basis of toxicity and immunity in contact-dependent growth inhibition (CDI) systems.

Authors:  Robert P Morse; Kiel C Nikolakakis; Julia L E Willett; Elias Gerrick; David A Low; Christopher S Hayes; Celia W Goulding
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

3.  Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.

Authors:  Wei Li; Ashutosh Upadhyay; Fabio L Fontes; E Jeffrey North; Yuehong Wang; Debbie C Crans; Anna E Grzegorzewicz; Victoria Jones; Scott G Franzblau; Richard E Lee; Dean C Crick; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

4.  SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.

Authors:  Kapil Tahlan; Regina Wilson; David B Kastrinsky; Kriti Arora; Vinod Nair; Elizabeth Fischer; S Whitney Barnes; John R Walker; David Alland; Clifton E Barry; Helena I Boshoff
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

5.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

6.  Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system.

Authors:  Anna Milano; Maria Rosalia Pasca; Roberta Provvedi; Anna Paola Lucarelli; Giulia Manina; Ana Luisa de Jesus Lopes Ribeiro; Riccardo Manganelli; Giovanna Riccardi
Journal:  Tuberculosis (Edinb)       Date:  2008-10-11       Impact factor: 3.131

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence.

Authors:  Scott E Converse; Joseph D Mougous; Michael D Leavell; Julie A Leary; Carolyn R Bertozzi; Jeffery S Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

9.  MmpL genes are associated with mycolic acid metabolism in mycobacteria and corynebacteria.

Authors:  Cristian Varela; Doris Rittmann; Albel Singh; Karin Krumbach; Kiranmai Bhatt; Lothar Eggeling; Gurdyal S Besra; Apoorva Bhatt
Journal:  Chem Biol       Date:  2012-04-20

10.  RND transporters protect Corynebacterium glutamicum from antibiotics by assembling the outer membrane.

Authors:  Liang Yang; Shuo Lu; Juan Belardinelli; Emilie Huc-Claustre; Victoria Jones; Mary Jackson; Helen I Zgurskaya
Journal:  Microbiologyopen       Date:  2014-06-18       Impact factor: 3.139

View more
  16 in total

1.  Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.

Authors:  Juan Manuel Belardinelli; Amira Yazidi; Liang Yang; Lucien Fabre; Wei Li; Benoit Jacques; Shiva Kumar Angala; Isabelle Rouiller; Helen I Zgurskaya; Jurgen Sygusch; Mary Jackson
Journal:  ACS Infect Dis       Date:  2016-09-01       Impact factor: 5.084

2.  Structural and functional evidence that lipoprotein LpqN supports cell envelope biogenesis in Mycobacterium tuberculosis.

Authors:  Geoff C Melly; Haley Stokas; Jennifer L Dunaj; Fong Fu Hsu; Malligarjunan Rajavel; Chih-Chia Su; Edward W Yu; Georgiana E Purdy
Journal:  J Biol Chem       Date:  2019-08-30       Impact factor: 5.157

Review 3.  RND transporters in the living world.

Authors:  Hiroshi Nikaido
Journal:  Res Microbiol       Date:  2018-03-22       Impact factor: 3.992

4.  MmpL3 is the flippase for mycolic acids in mycobacteria.

Authors:  Zhujun Xu; Vladimir A Meshcheryakov; Giovanna Poce; Shu-Sin Chng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-11       Impact factor: 11.205

5.  Iron Acquisition in Mycobacterium tuberculosis.

Authors:  Alex Chao; Paul J Sieminski; Cedric P Owens; Celia W Goulding
Journal:  Chem Rev       Date:  2018-11-26       Impact factor: 60.622

6.  Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.

Authors:  John T Williams; Elizabeth R Haiderer; Garry B Coulson; Kayla N Conner; Edmund Ellsworth; Chao Chen; Nadine Alvarez-Cabrera; Wei Li; Mary Jackson; Thomas Dick; Robert B Abramovitch
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

7.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

8.  Computational design of MmpL3 inhibitors for tuberculosis therapy.

Authors:  R Chaitra; Rohit Gandhi; N Jayanna; Sachin Satyanath; Parasuraman Pavadai; Manikanta Murahari
Journal:  Mol Divers       Date:  2022-04-28       Impact factor: 2.943

9.  Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.

Authors:  Sandeep Thanna; Steven J Sucheck
Journal:  Medchemcomm       Date:  2015-10-16       Impact factor: 3.597

10.  MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine.

Authors:  Chih-Chia Su; Philip A Klenotic; Jani Reddy Bolla; Georgiana E Purdy; Carol V Robinson; Edward W Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.